“Genedata Screener has become the software of choice for screening data analysis in pharma and bio-pharma industries,” Dr. Othmar Pfannes, CEO of Genedata, said in a press release. “Therefore, we’re seeing increased Screener adoption by leading CROs, such as Evotec, who see quantifiable value in using the same data analysis methodology used by their customers. Genedata is committed to increasing that value by investing in our software so that it continually keeps pace with new business concepts, technologies and workflows as they arise.”